<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To explore the prevalence of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> in patients with <z:hpo ids='HP_0000822'>hypertension</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and to identify possible mechanisms for the development of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A community-based, cross-sectional observational study was conducted in the primary health care in Skara, Sweden, and 1739 subjects (798 men, 941 women) were surveyed </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were categorized as those with <z:hpo ids='HP_0000822'>hypertension</z:hpo> only (n = 597); those with both <z:hpo ids='HP_0000822'>hypertension</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 171), and those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> only (n = 147) </plain></SENT>
<SENT sid="3" pm="."><plain>In the reference population, 824 normotensive subjects without <z:mp ids='MP_0002055'>diabetes</z:mp> were identified and used as controls </plain></SENT>
<SENT sid="4" pm="."><plain>Participants were examined for <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> including fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, serum insulin, blood pressure, <z:chebi fb="23" ids="18059">lipids</z:chebi> and anthropometric measures </plain></SENT>
<SENT sid="5" pm="."><plain>Resting electrocardiogram (ECG) was recorded and Minnesota-coded </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> was measured by the homeostasis model assessment (HOMA) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Age-adjusted prevalence of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> was 2% in patients with <z:hpo ids='HP_0000822'>hypertension</z:hpo> only, 6% in patients with both <z:hpo ids='HP_0000822'>hypertension</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 4% in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> only and 2% in controls, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Age and sex adjusted odds ratios (OR) (95% CI) were; <z:hpo ids='HP_0000822'>hypertension</z:hpo> 0.7 (0.30-1.5), combined <z:hpo ids='HP_0000822'>hypertension</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> 3.3 (1.6-6.7), and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> 2.0 (0.9-4.7) </plain></SENT>
<SENT sid="9" pm="."><plain>The association with combined <z:hpo ids='HP_0000822'>hypertension</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> remained significant when adjusted for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) risk factors and body mass index (BMI), was attenuated with adjustment for ischemic ECG; 2.4 (1.1-5.0) and lost significance with adjustment for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>; 1.3 (0.5-3.1) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> is associated with the combined occurrence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> may be a common underlying mechanism </plain></SENT>
</text></document>